M&A Deal Summary

Hill Acquires Lexaria Canpharm ULC

On December 10, 2020, Hill acquired consumer products company Lexaria Canpharm ULC from Lexaria Bioscience

Acquisition Highlights
  • This is Hill’s 2nd transaction in the Consumer Products sector.
  • This is Hill’s 2nd transaction in Canada.
  • This is Hill’s 1st transaction in British Columbia.

M&A Deal Summary
Date 2020-12-10
Target Lexaria Canpharm ULC
Sector Consumer Products
Buyer(s) Hill
Sellers(s) Lexaria Bioscience
Deal Type Divestiture

Target

Lexaria Canpharm ULC

Kelowna, British Columbia, Canada
Lexaria Canpharm ULC engages in the production of non-pharmaceutical products containing 0.3% or greater THC and other psychoactive cannabinoids.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hill

Toronto, Ontario, Canada
Category Company
Founded 2008
Sector Beverages
Revenue 3M CAD (2023)
DESCRIPTION

Hill Street is the world's most award-winning company exclusively focused on alcohol-free beer, wine, and adult-format beverages. Hill Street's great-tasting products include Hill Street Craft Brewed Lager, Designated Draft alcohol-free beer, Vin(Zero) wines, and Vintense wines, and have won numerous medals and accolades including three Gold, two Silver, and two Bronze Medals at the U.S. Open Beer Championships, the Retail Council of Canada's Grand Prix award, and a prestigious Double Gold Medal at the San Francisco International Wine Challenge. Hill Street was founded in 2008 and is based in Toronto, Canada.

DEAL STATS #
Overall 2 of 2
Sector (Consumer Products) 2 of 2
Type (Divestiture) 1 of 1
State (British Columbia) 1 of 1
Country (Canada) 2 of 2
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-28 OneLeaf Cannabis

Regina, Saskatchewan, Canada

OneLeaf Cannabis Corp. is a privately-owned craft-inspired cannabis cultivation and processing company. OneLeaf has constructed a 48,200 square foot facility purpose-built to EU GMP standards that incorporate vertical farming, LED lighting and advanced HVAC and automation systems. Phase 1 of OneLeaf's facility, which is substantially complete and in preparation to complete its evidence package, is comprised of approximately 17,000 square feet. Upon licensing, OneLeaf will own a vast collection of unique cannabis genetics with differentiated attributes and properties and intend to research and develop consumer, medical, and therapeutic products based on the diverse cannabinoid content found within its collection.

Buy -

Seller(S) 1

SELLER

Lexaria Bioscience

Kelowna, British Columbia, Canada
Category Company
Founded 2004
Sector Life Science
Employees5
Revenue 1M USD (2021)
DESCRIPTION

Lexaria Bioscience's proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. Lexaria Bioscience was founded in 2004 and is headquartered in Kelowna, British Columbia.

DEAL STATS #
Overall 1 of 1
Sector (Consumer Products) 1 of 1
Type (Divestiture) 1 of 1
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2020) 1 of 1
Mergr

Product

Company

Legal